Mozambique vs Nigeria: Cause of death, by non-communicable diseases, male
Mozambique
28.2%
in 2021
Nigeria
27.8%
in 2021
Mozambique rank
174th
Nigeria rank
176th
Cause of death, by non-communicable diseases, male over time
- Mozambique
- Nigeria
How they compare
Mozambique currently reports 28.2% against 27.8% in Nigeria, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Nigeria ahead.
Mozambique ranks 174th and Nigeria ranks 176th of 185 countries.
Across the 3 decades both report, Mozambique averaged higher in 2 and Nigeria in 1.
Head to head by decade
| Decade | Mozambique | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.7% | 18.2% | 0.5% | Nigeria |
| 2010s | 29.4% | 23.4% | 6.0% | Mozambique |
| 2020s | 30.4% | 27.2% | 3.2% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Mozambique or Nigeria?
- Mozambique, at 28.2% against 27.8% in Nigeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Mozambique and Nigeria?
- 0.4%, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Nigeria?
- 6 years are reported by both, from 2000 to 2021.
- How do Mozambique and Nigeria rank globally for cause of death, by non-communicable diseases, male?
- Mozambique ranks 174th and Nigeria ranks 176th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.